Chronic Bronchitis Affects Outcomes in Smokers without Chronic Obstructive Pulmonary Disease (COPD)

Area of Science:

• Pulmonology
• Respiratory Medicine
• Clinical Research

Background:

• Chronic bronchitis (CB) is a known complication in smokers with Chronic Obstructive Pulmonary Disease (COPD).
• The impact of CB on smokers without COPD is less understood and often overlooked.
• This study investigates CB effects in smokers with and without COPD.

Purpose of the Study:

• To examine the clinical outcomes of chronic bronchitis in smokers without COPD.
• To compare these outcomes with those of smokers who have COPD.
• To highlight the significance of CB in non-COPD smokers.

Main Methods:

• A 10-year prospective study of 511 smokers (302 with COPD, 209 without COPD).
• Chronic bronchitis defined by cough and sputum for >=3 months/year for 2 consecutive years.
• Evaluated spirometry, DLco, 6MWT, mMRC, CAT, exacerbation frequency, and all-cause mortality.

Main Results:

• 27% of smokers without COPD and 45% with COPD had chronic bronchitis.
• Smokers without COPD with CB showed reduced lung function (FEV1, DLco), poorer exercise capacity (6MWT), increased dyspnea, more exacerbations, and lower survival compared to those without CB.
• CB did not accelerate FEV1 decline in smokers without COPD, but it did in those with COPD.

Conclusions:

• Chronic bronchitis in smokers without COPD significantly worsens symptoms, quality of life, and survival.
• Recognizing and managing chronic bronchitis in smokers without COPD is essential.
• Findings emphasize the clinical importance of addressing CB even in the absence of diagnosed COPD.